Heron Therapeutics Inc
|Market Cap (Intraday)||1.61B|
|2yr Forward PE||N/A|
Heron Therapeutics Inc Stock, NASDAQ:HRTX
Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.